TGFBI secreted by TAMs in ovarian cancer contributed to an immunosuppressive TME and promoted cell migration, and meanwhile, anti-TGFBI antibody treatment reduced peritoneal tumor size in the orthotopic mouse model 56, 57. The gene discussed is TGFBI; the disease is ovarian carcinoma.